Kumar Rakhi has filed 36 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 1153 shares of NeuroPace Inc ($NPCE) on March 20, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | NeuroPace Inc | $NPCE | Kumar Rakhi | Director | A | Common Stock | 1153 | $13.00 | 19,160.0000 | 33,307,734 | 6.40% | 0.00% |
| Dec. 19, 2025 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 904 | $16.59 | 18,007.0000 | 33,307,734 | 5.29% | 0.00% |
| Sept. 19, 2025 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 1509 | $9.94 | 17,103.0000 | 32,560,130 | 9.68% | 0.00% |
| Sept. 29, 2023 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 1541 | $9.73 | 4,881.0000 | 0 | 46.14% | 0.00% |
| June 30, 2023 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 3340 | $4.49 | 3,340.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2025 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 1440 | $10.41 | 15,594.0000 | 32,560,130 | 10.17% | 0.00% |
| March 21, 2025 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 1247 | $12.02 | 14,154.0000 | 32,560,130 | 9.66% | 0.00% |
| Dec. 21, 2024 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 1300 | $11.53 | 12,907.0000 | 0 | 11.20% | 0.00% |
| Sept. 30, 2024 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 2152 | $6.97 | 11,607.0000 | 0 | 22.76% | 0.00% |
| June 28, 2024 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 1984 | $7.56 | 9,455.0000 | 0 | 26.56% | 0.00% |
| March 29, 2024 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 1136 | $13.20 | 7,471.0000 | 0 | 17.93% | 0.00% |
| Dec. 29, 2023 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Common Stock | 1454 | $10.31 | 6,335.0000 | 0 | 29.79% | 0.00% |
| June 6, 2025 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Stock Option (right to buy) | 8745 | $0.00 | 8,745.0000 | 32,560,130 | 9999.99% | 0.03% |
| Feb. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 958 | $10.72 | 162,306.0000 | 731,318,202 | 0.59% | 0.00% |
| Feb. 13, 2025 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | M | Stock Option (Right to Buy) | 187500 | $0.00 | 312,500.0000 | 731,318,202 | 37.50% | 0.03% |
| Feb. 13, 2025 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | M | Common Shares | 187500 | $3.85 | 390,764.0000 | 731,318,202 | 92.24% | 0.03% |
| Feb. 13, 2025 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | S | Common Shares | 227500 | $10.43 | 163,264.0000 | 731,318,202 | 58.22% | 0.03% |
| Jan. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 1057 | $11.15 | 203,264.0000 | 731,318,202 | 0.52% | 0.00% |
| Dec. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 3087 | $11.57 | 204,321.0000 | 735,642,721 | 1.49% | 0.00% |
| Nov. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 958 | $11.49 | 207,408.0000 | 735,642,721 | 0.46% | 0.00% |
| Oct. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 956 | $11.92 | 208,366.0000 | 735,642,721 | 0.46% | 0.00% |
| Sept. 23, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | S | Common Shares | 250000 | $11.89 | 209,322.0000 | 831,049,444 | 54.43% | 0.03% |
| Sept. 23, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | M | Stock Option (Right to Buy) | 250000 | $0.00 | 500,000.0000 | 831,049,444 | 33.33% | 0.03% |
| Sept. 23, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | M | Common Shares | 250000 | $3.85 | 459,322.0000 | 831,049,444 | 119.43% | 0.03% |
| Sept. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 3087 | $11.97 | 209,322.0000 | 831,049,444 | 1.45% | 0.00% |
| Aug. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 958 | $11.48 | 212,409.0000 | 831,049,444 | 0.45% | 0.00% |
| July 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 958 | $11.00 | 213,367.0000 | 831,049,444 | 0.45% | 0.00% |
| June 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 3087 | $10.80 | 212,123.0000 | 831,049,444 | 1.43% | 0.00% |
| June 7, 2024 | NeuroPace Inc | $NPCE | Kumar Rakhi | Not found | A | Stock Option (Rt to Buy) | 17774 | $0.00 | 17,774.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 1363 | $11.37 | 215,210.0000 | 831,049,444 | 0.63% | 0.00% |
| April 22, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | A | Stock Option (Right to Buy) | 230548 | $0.00 | 230,548.0000 | 831,049,444 | 9999.99% | 0.03% |
| April 22, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | A | Common Shares | 38685 | $0.00 | 216,573.0000 | 831,049,444 | 15.16% | 0.00% |
| April 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 9881 | $10.46 | 177,888.0000 | 831,049,444 | 5.26% | 0.00% |
| March 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 1506 | $10.01 | 187,769.0000 | 712,791,115 | 0.80% | 0.00% |
| Feb. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 1508 | $11.54 | 189,275.0000 | 712,791,115 | 0.79% | 0.00% |
| Jan. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Kumar Rakhi | Chief Accounting Officer | F | Common Shares | 1506 | $10.35 | 190,783.0000 | 712,791,115 | 0.78% | 0.00% |